Mizuho cuts Belite Bio target price to $221 from $234
BLTE•Mizuho cut its target price for Belite Bio to $221 from $234.
Related News
Beyond Air schedules quarterly financial results conference call
XAIR•
Alnylam Pharmaceuticals Q3 revenue rises on AMVUTTRA demand
ALNY•
Fluent publishes update to financial calendar
FLNT•
BorgWarner wins inverter supply contract for global automaker's future electric vehicles
BWA•
Incyte raises 2026 net sales forecast to $5.21 billion-$5.3 billion
INCY•